2007Zhejiang Medical JournalRequires access

Effect of alendronate on proliferation and osteogenic differentiation in MG-63 cells

Jie Feng

Open publisher page 0 citations

Abstract

Objective To investigate the effect of alendronate on proliferation and osteogenic differentiation in MG-63 cells. Methods MG-63 cells were divided into five groups: negative control (medium alone), positive control(treated with 10-8M dexamethasone), three experimental groups( treated with 10-6M, 10-8M, 10-10M alendronate respectively). After a few days, we analyzed the outcome. Cell proliferation was determined by MTT; Osteogenic differentiation of BMSC was evaluated by alkaline phosphatase bioassay; Gene expression assesses was by RT-PCR. Results alendronate significantly increased the cell number over controls, attaining peak levels at a concentration of 10-8M. Alkaline phosphatase activity was increased. Gene expression of BMP-2, Type I collagen and osteocalcin was enhanced. Conclusion Alendronate, aside from its role as inhibitor of osteoclastic bone resorption, is promoter of osteoblast proliferation and maturation.

About this research paper

What this paper is about

Objective To investigate the effect of alendronate on proliferation and osteogenic differentiation in MG-63 cells. Methods MG-63 cells were divided into five groups: negative control (medium alone), positive control(treated with 10-8M dexamethasone), three experimental groups( treated with 10-6M, 10-8M, 10-10M alendronate respectively). After a few days, we analyzed the outcome. Cell proliferation was determined by MTT; Osteogenic differentiation of BMSC was evaluated by alkaline phosphatase bioassay; Gene expression assesses was by RT-PCR. Results alendronate significantly increased the cell number over controls, attaining peak levels at a concentration of 10-8M. Alkaline phosphatase activity was increased. Gene expression of BMP-2, Type I collagen and osteocalcin was enhanced. Conclusion Alendronate, aside from its role as inhibitor of osteoclastic bone resorption, is promoter of osteoblast proliferation and maturation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of alendronate on proliferation and osteogenic differentiation in MG-63 cells. Methods MG-63 cells were divided into five groups: negative control (medium alone), positive control(treated with 10-8M dexamethasone), three experimental groups( treated with 10-6M, 10-8M, 10-10M alendronate respectively). After a few days, we analyzed the outcome. Cell proliferation was determined by MTT; Osteogenic differentiation of BMSC was evaluated by alkaline phosphatase bioassay; Gene expression assesses was by RT-PCR. Results alendronate significantly increased the cell number over controls, attaining peak levels at a concentration of 10-8M. Alkaline phosphatase activity was increased. Gene expression of BMP-2, Type I collagen and osteocalcin was enhanced. Conclusion Alendronate, aside from its role as inhibitor of osteoclastic bone resorption, is promoter of osteoblast proliferation and maturation.

Key concepts: Osteocalcin, Alkaline phosphatase, Osteoblast, Medicine, Cell growth, Bone resorption, Dexamethasone, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of alendronate on proliferation and osteogenic differentiation in MG-63 cells — Research Paper | ScholarLens